Nosopharm
PrivateLast Round
Debt
Feb 12, 2018
Total Funding Raised
$1.2M
Company Overview
Nosopharm is a biotechnology company that specializes in the research and development of new anti-infective drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nosopharm Comps
Public and private peers based on sector, stage, and business model.
Nosopharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 12, 2018 | ||||
| VC Round | Mar 28, 2017 |
Nosopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alto Invest | VC Round |
| Kreaxi | VC Round |
| Région Occitanie | Grant |
| Auriga Partners | VC Round |
| Bpifrance | Grant, Debt |
| Direction générale de l'armement (DGA) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2018
$1.2M round led by Bpifrance
- Mar 28, 2017
Raised $2.6M from Alto Invest, Auriga Partners, and Kreaxi.
Nosopharm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nosopharm's valuation, stock price, and market status.
